Literature DB >> 12892352

Necrotizing soft tissue infections: a primary care review.

Adrienne J Headley1.   

Abstract

Patients with necrotizing soft tissue infections often present initially to family physicians. These infections must be detected and treated rapidly to prevent loss of limb or a fatal outcome. Unfortunately, necrotizing soft tissue infections have no pathognomonic signs. Patients may present with some evidence of cellulitis, vesicles, bullae, edema, crepitus, erythema, and fever. They also may complain of pain that seems out of proportion to the physical findings; as the infection progresses, their pain may decrease. Magnetic resonance imaging and laboratory findings such as acidosis, anemia, electrolyte abnormalities, coagulopathy, and an elevated white blood cell count may provide clues to the diagnosis. No single organism or combination of organisms is consistently responsible for necrotizing soft tissue infections. Most infections are polymicrobial, with both anaerobic and aerobic bacteria frequently present. Fungal infections also have been reported. Generally, bacterial and toxin-related effects converge to cause skin necrosis, shock, and multisystem organ failure. Aggressive debridement of infected tissues is critical to management. Antimicrobial therapy is important but remains secondary to the removal of diseased and necrotic tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892352

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  38 in total

1.  Fournier's gangrene.

Authors:  Cemil Kavalci; Yunsur Cevik; Polat Durukan; Osman Temizoz
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

2.  Pyelonephritis can be a source of a life-threatening necrotizing myofasciitis.

Authors:  Haytham Kamel; Mohamed Soliman Edris Edinburgh Awed; Ahmed Fouad Kotb
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

3.  Necrotising soft-tissue infection.

Authors:  Miguel F Carrascosa; Mariano Pérez Santamaría; José-Ramón Salcines Caviedes; Pablo G Gutiérrez
Journal:  BMJ Case Rep       Date:  2012-10-10

4.  Necrotizing fasciitis: is the bacterial spectrum changing?

Authors:  Serafim Tsitsilonis; Claudia Druschel; Florian Wichlas; Norbert P Haas; Philipp Schwabe; Hermann-Josef Bail; Klaus-Dieter Schaser
Journal:  Langenbecks Arch Surg       Date:  2012-07-26       Impact factor: 3.445

Review 5.  Necrotizing fasciitis: an urgent diagnosis.

Authors:  Silvia Paz Maya; Delfina Dualde Beltrán; Pierre Lemercier; Carlos Leiva-Salinas
Journal:  Skeletal Radiol       Date:  2014-01-29       Impact factor: 2.199

6.  Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection.

Authors:  Morag R Graham; Kimmo Virtaneva; Stephen F Porcella; Donald J Gardner; R Daniel Long; Diane M Welty; William T Barry; Claire A Johnson; Larye D Parkins; Fred A Wright; James M Musser
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

7.  Rapid identification of pathogens responsible for necrotizing fasciitis on an integrated microfluidic system.

Authors:  Ju-Ching Yu; Pang-Hsin Hsieh; Hsing-Wen Tsai; Wen-Hsin Chang; Ting-Hang Liu; Mel S Lee; Kuo-Ti Peng; Kuo-Chin Huang; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2017-12-12       Impact factor: 2.800

8.  Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study.

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Chih-Chun Tsai; Chih-Wei Tseng; Yu-Hsi Hsieh
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

Review 9.  Imaging of musculoskeletal soft tissue infections.

Authors:  Marcin B Turecki; Mihra S Taljanovic; Alana Y Stubbs; Anna R Graham; Dean A Holden; Tim B Hunter; Lee F Rogers
Journal:  Skeletal Radiol       Date:  2009-08-28       Impact factor: 2.199

10.  Cellulitis incidence in a defined population.

Authors:  S M Ellis Simonsen; E R van Orman; B E Hatch; S S Jones; L H Gren; K T Hegmann; J L Lyon
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.